Literature DB >> 27507690

Isolated brain metastasis from a small renal mass.

Christopher J D Wallis1, Michelle R Downes2, Georg Bjarnason3, Raj Satkunasivam4.   

Abstract

The identification of small renal masses is increasing. Active surveillance is a guideline-approved management strategy for select patients with small renal masses. Metastases during the observation of small renal masses are uncommon, and no cases of brain metastasis have been reported. We report the case of a 73-year-old man who presented with tonic-clonic seizures as the result of a brain metastasis from a small renal mass (3.5 cm in maximal dimension). Treatment with whole brain radiotherapy was undertaken successfully. The patient will undergo surveillance with consideration for systemic therapy at the time of progression. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27507690      PMCID: PMC4986040          DOI: 10.1136/bcr-2016-216081

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

2.  Guideline for management of the clinical T1 renal mass.

Authors:  Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

3.  Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.

Authors:  Mesut Remzi; Mehmet Ozsoy; Hans-Christoph Klingler; Martin Susani; Matthias Waldert; Christian Seitz; Joerg Schmidbauer; Michael Marberger
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

Review 4.  Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

Authors:  Marc C Smaldone; Alexander Kutikov; Brian L Egleston; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Michael A Jewett; Richard E Greenberg; Robert G Uzzo
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

Review 5.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

6.  Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.

Authors:  B Ljungberg; F I Alamdari; T Rasmuson; G Roos
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

7.  Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2003-05       Impact factor: 6.394

8.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer.

Authors:  Michael A S Jewett; Kamal Mattar; Joan Basiuk; Christopher G Morash; Stephen E Pautler; D Robert Siemens; Simon Tanguay; Ricardo A Rendon; Martin E Gleave; Darrel E Drachenberg; Raymond Chow; Hannah Chung; Joseph L Chin; Neil E Fleshner; Andrew J Evans; Brenda L Gallie; Masoom A Haider; John R Kachura; Ghada Kurban; Kimberly Fernandes; Antonio Finelli
Journal:  Eur Urol       Date:  2011-04-01       Impact factor: 20.096

9.  Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.

Authors:  John C Cheville; Christine M Lohse; Horst Zincke; Amy L Weaver; Bradley C Leibovich; Igor Frank; Michael L Blute
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

10.  Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.

Authors:  Brian Shuch; Jeff C La Rochelle; Tobias Klatte; Stephen B Riggs; Weiqing Liu; Fairooz F Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.